It was revealed by Liu et al. that high GLDC expression inhibited stem cell injury in chronic myeloid leukemia [47], and was aberrantly expressed in AML clinical samples [42]. Here, GLDC is linked to chronic myelogenous leukemia, BCR-ABL1 positive.